X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS BIOCON LTD DR. DATSONS LABS/
BIOCON LTD
 
P/E (TTM) x -10.9 79.5 - View Chart
P/BV x 0.2 7.5 2.2% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 DR. DATSONS LABS   BIOCON LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
BIOCON LTD
Mar-17
DR. DATSONS LABS/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs1261,162 10.8%   
Low Rs31483 6.4%   
Sales per share (Unadj.) Rs133.0194.6 68.4%  
Earnings per share (Unadj.) Rs0.234.4 0.4%  
Cash flow per share (Unadj.) Rs6.648.3 13.7%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.1 0.0%  
Book value per share (Unadj.) Rs128.8241.9 53.2%  
Shares outstanding (eoy) m31.66200.00 15.8%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.2 13.9%   
Avg P/E ratio x516.123.9 2,159.7%  
P/CF ratio (eoy) x11.817.0 69.5%  
Price / Book Value ratio x0.63.4 17.9%  
Dividend payout %02.9 0.0%   
Avg Mkt Cap Rs m2,477164,440 1.5%   
No. of employees `000NA9.2 0.0%   
Total wages/salary Rs m567,470 0.7%   
Avg. sales/employee Rs ThNM4,213.9-  
Avg. wages/employee Rs ThNM809.0-  
Avg. net profit/employee Rs ThNM745.2-  
INCOME DATA
Net Sales Rs m4,21138,911 10.8%  
Other income Rs m791,571 5.0%   
Total revenues Rs m4,28940,482 10.6%   
Gross profit Rs m5699,795 5.8%  
Depreciation Rs m2042,772 7.4%   
Interest Rs m430260 165.5%   
Profit before tax Rs m138,334 0.2%   
Minority Interest Rs m0163 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,616 0.4%   
Profit after tax Rs m56,881 0.1%  
Gross profit margin %13.525.2 53.6%  
Effective tax rate %48.019.4 247.7%   
Net profit margin %0.117.7 0.6%  
BALANCE SHEET DATA
Current assets Rs m6,85240,477 16.9%   
Current liabilities Rs m6,71116,783 40.0%   
Net working cap to sales %3.360.9 5.5%  
Current ratio x1.02.4 42.3%  
Inventory Days Days16160 269.9%  
Debtors Days Days31883 384.4%  
Net fixed assets Rs m3,67345,073 8.1%   
Share capital Rs m3171,000 31.7%   
"Free" reserves Rs m3,76147,377 7.9%   
Net worth Rs m4,07848,377 8.4%   
Long term debt Rs m1,67121,082 7.9%   
Total assets Rs m12,63393,942 13.4%  
Interest coverage x1.033.1 3.1%   
Debt to equity ratio x0.40.4 94.0%  
Sales to assets ratio x0.30.4 80.5%   
Return on assets %3.47.6 45.3%  
Return on equity %0.114.2 0.8%  
Return on capital %7.712.6 60.9%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96412,988 7.4%   
Fx outflow Rs m6077,899 7.7%   
Net fx Rs m3575,089 7.0%   
CASH FLOW
From Operations Rs m1,3456,400 21.0%  
From Investments Rs m-2,256-4,985 45.2%  
From Financial Activity Rs m-1,200-1,775 67.6%  
Net Cashflow Rs m-2,111-473 446.2%  

Share Holding

Indian Promoters % 4.5 40.4 11.2%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 0.0 8.4 -  
FIIs % 1.4 10.7 12.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 19.9 472.9%  
Shareholders   20,807 109,995 18.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   STERLING BIOTECH  SANOFI INDIA  ALKEM LABORATORIES  ORCHID PHARMA LTD  PFIZER  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS